• The document is an intimation of an Analyst/Investor Meeting, specifically participation in the 'Nomura Investment Forum (Asia) 2026' conference.
  • The event is scheduled for Wednesday, June 03, 2026 in Singapore.
  • The event mode is In-person and is scheduled to begin at 10.00 A.M Singapore Time (SGT) onwards.
  • The stated purpose is a meeting with Analyst(s)/Institutional Investor(s) as part of the forum.
  • The intimation does not specify if the meeting is scheduled before or after an earnings announcement.
  • Management participants are not listed in this disclosure.
  • A presentation for the meeting is provided and will be made available. The link is: STARHEALTH29042026111712_ECPresentationQ4FY26V2.pdf.
  • The presentation will also be available on the Company's website at www.starhealth.in.
  • The disclosure includes a standard note that the meeting is "subject to changes that may happen due to exigencies." It does not contain explicit compliance language stating that no unpublished price sensitive information (UPSI) will be shared.
  • No financial highlights, guidance references, or presentation summaries are included in this specific intimation document.

Additional Notes Section

  • The document is a regulatory filing made in compliance with SEBI LODR Regulations (Regulation 30 read with Schedule III).
  • It is addressed to the listing departments of BSE Limited and the National Stock Exchange of India Limited.
  • The reference number for the filing is SHAI/B & S/SE/29/2026-27.
  • The letter is signed by Jayashree Sethuraman, designated as Company Secretary & Compliance Officer.
  • The document itself does not contain any financial data; it is purely an intimation of an event.
  • Logistical details like dial-in numbers are not provided, as the event is in-person.